Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis

Cell Reports
Thomas McKerrellGeorge S Vassiliou

Abstract

Clonal hemopoiesis driven by leukemia-associated gene mutations can occur without evidence of a blood disorder. To investigate this phenomenon, we interrogated 15 mutation hot spots in blood DNA from 4,219 individuals using ultra-deep sequencing. Using only the hot spots studied, we identified clonal hemopoiesis in 0.8% of individuals under 60, rising to 19.5% of those ≥90 years, thus predicting that clonal hemopoiesis is much more prevalent than previously realized. DNMT3A-R882 mutations were most common and, although their prevalence increased with age, were found in individuals as young as 25 years. By contrast, mutations affecting spliceosome genes SF3B1 and SRSF2, closely associated with the myelodysplastic syndromes, were identified only in those aged >70 years, with several individuals harboring more than one such mutation. This indicates that spliceosome gene mutations drive clonal expansion under selection pressures particular to the aging hemopoietic system and explains the high incidence of clonal disorders associated with these mutations in advanced old age.

References

Oct 1, 1976·Science·P C Nowell
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·A M FordM Greaves
Feb 22, 2002·The New England Journal of Medicine·Robert A KyleL Joseph Melton
Oct 24, 2003·Nature·L M CalviD T Scadden
Jun 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Derrick J RossiIrving L Weissman
Jul 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Mario F FragaManel Esteller
Aug 7, 2007·PLoS Biology·Stuart M ChambersMargaret A Goodell
Feb 26, 2008·Cell·Derrick J RossiIrving L Weissman
Oct 7, 2008·Scandinavian Journal of Clinical and Laboratory Investigation·Eli TaraldsrudTorstein Egeland
Jun 10, 2009·Bioinformatics·Heng LiUNKNOWN 1000 Genome Project Data Processing Subgroup
Mar 20, 2010·BMC Bioinformatics·Zhiyong ShenChenggang Zhang
Jun 15, 2011·Current Opinion in Immunology·Carolien M WoolthuisGerwin Huls
May 9, 2012·Nature Genetics·Cathy C LaurieBruce S Weir
Aug 11, 2012·PloS One·Virag VasHartmut Geiger
May 25, 2013·Blood·Jan KrönkeKonstanze Döhner
Sep 14, 2013·Blood·Elli PapaemmanuilUNKNOWN Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium
Oct 19, 2013·Blood·Mario CazzolaLuca Malcovati
Apr 12, 2014·American Journal of Hematology·Chien-Chin LinHwei-Fang Tien
Oct 31, 2014·Nucleic Acids Research·Simon A ForbesPeter J Campbell
Nov 27, 2014·The New England Journal of Medicine·Siddhartha JaiswalBenjamin L Ebert
Nov 27, 2014·The New England Journal of Medicine·Giulio GenoveseSteven A McCarroll

❮ Previous
Next ❯

Citations

Dec 3, 2015·Blood·Virginie ChesnaisUNKNOWN Groupe Francophone des Myélodysplasies
Jan 13, 2016·Proceedings of the National Academy of Sciences of the United States of America·Andrii I RozhokJames DeGregori
Jan 29, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jing YangJun Qian
Jul 22, 2015·Proceedings of the National Academy of Sciences of the United States of America·Andrii I Rozhok, James DeGregori
Jan 20, 2016·Science·Margaret A Goodell, Thomas A Rando
Feb 10, 2016·Proceedings of the National Academy of Sciences of the United States of America·Geoffrey J MaherAndrew O M Wilkie
Jun 17, 2016·Molecular & Cellular Oncology·Isabelle PloWilliam Vainchenker
Dec 19, 2015·Nature Reviews. Cancer·Luis C FernándezFrancisco X Real
Sep 26, 2015·Science·Iñigo Martincorena, Peter J Campbell
Dec 15, 2015·Annals of the New York Academy of Sciences·Aditi VediElisa Laurenti
Nov 28, 2015·Trends in Immunology·Michael D DenkingerHartmut Geiger
Oct 7, 2015·International Journal of Hematology·Liran I ShlushAndre C Schuh
Nov 23, 2015·Best Practice & Research. Clinical Haematology·Brunangelo Falini, Maria Paola Martelli
Nov 23, 2015·Best Practice & Research. Clinical Haematology·Liran I Shlush, Amanda Mitchell
Aug 19, 2015·Nature Genetics·Joseph SalibaIsabelle Plo
Sep 25, 2015·Science Translational Medicine·Thomas McKerrell, George S Vassiliou
Apr 12, 2016·British Journal of Haematology·Carolyn S GroveGeorge S Vassiliou
Jun 6, 2015·Cell Stem Cell·Peter D AdamsK Lenhard Rudolph
Jun 9, 2016·The New England Journal of Medicine·Elli PapaemmanuilPeter J Campbell
Jun 18, 2016·Leukemia·D C Link, M J Walter
Jul 9, 2016·British Journal of Haematology·Luca Malcovati, Mario Cazzola
Oct 22, 2016·Current Opinion in Cell Biology·Bartomeu Colom, Philip H Jones
Jul 13, 2016·Experimental Hematology·Bettina M Moehrle, Hartmut Geiger
Jul 7, 2016·Trends in Molecular Medicine·Shailaja Akunuru, Hartmut Geiger
Aug 23, 2016·Nature Communications·Andrew L YoungTodd E Druley
Aug 27, 2016·Blood·George S Vassiliou
Oct 11, 2016·Leukemia·B C MedeirosR Swords
Dec 3, 2016·Leukemia·H P Koeffler, G Leong
Nov 1, 2016·International Journal of Hematology·Claire Mazumdar, Ravindra Majeti
Dec 29, 2016·Blood·William Vainchenker, Robert Kralovics
Dec 23, 2016·Cold Spring Harbor Perspectives in Medicine·Lorenzo BrunettiMargaret A Goodell
Mar 30, 2017·Blood·Poorval JoshiOmar Abdel-Wahab

❮ Previous
Next ❯

Methods Mentioned

BETA
exome-sequencing
PCR
MDS

Software Mentioned

MIDAS
BWA
MPRIMER
SAMTOOLS

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Cambridge Stem Cell Institute - Researcher Network

Cambridge Stem Cell Institute's mission is to transform human health through a deep understanding of stem cell biology. Follow this feed to stay up to date on research published in this group.

Related Papers

Blood
Mario CazzolaAssociazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Mikkael A Sekeres
© 2022 Meta ULC. All rights reserved